Viewing Study NCT04595734

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:18 AM
Ignite Modification Date: 2026-01-08 @ 4:03 AM
Study NCT ID: NCT04595734
Status: UNKNOWN
Last Update Posted: 2022-01-21
First Post: 2020-10-14
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Liver Toxicity in Lung Cancer Patients Treated With Immune-checkpoint Inhibitors.
Sponsor: Western Sydney Local Health District
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Cancer Stage IV View
None Lung Cancer, Non-small Cell View
None Hepatitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Immune-checkpoint inhibitors View
None Lung cancer View
None Nivolumab View
None Pembrolizumab View
None Durvalumab View